Live Analyst Rating Changes 23958 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Max Smock
WB

Max Smock

William Blair
Wall Street Analyst
★★★★★
#17
on 13Foresight · ranked by our own returns
95%
Success Rate
+18.5%
Average Return
20 of 21 calls profitable · +13.8% vs benchmark
S&P 500 (SPY)
📈 Across the calls we could measure, roughly 95% of Max Smock's ratings turned a profit when each position was held for 2 year — averaging +18.5% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

38 Buy 19 Hold 0 Sell
Max's Stock Coverage 13 ratings · 2026-08-13
Company Date Position Consensus ⓘ Price Target ⓘ 2-Yr Return vs S&P 500 ⓘ
CERT
Certara
 Jun 30, 2026 HOLD Buy
+63.3% avg upside
22 analysts
 — +22.0% ·
SHC
Sotera Health
 Jun 18, 2026 HOLD Strong Buy
+16.6% avg upside
13 analysts
 — +20.2% ·
CH:SFZN
Siegfried Holding AG
 Jun 18, 2026 HOLD Hold
+15.7% avg upside
3 analysts
 — +17.2% ·
SLP
Simulations Plus
 Jun 17, 2026 HOLD Buy
+106.8% avg upside
11 analysts
 — +0.4% ·
CRL
Charles River Labs
 Jun 02, 2026 BUY Strong Buy
-17.2% avg upside
35 analysts
 — +62.7% ·
ICLR
Icon
 Jun 02, 2026 BUY Strong Buy
+12.7% avg upside
26 analysts
 — +21.8% ·
COR
Cencora
 May 22, 2026 HOLD Buy
+2.2% avg upside
44 analysts
 — +17.9% ·
MCK
McKesson
 May 08, 2026 BUY Strong Buy
-13.2% avg upside
28 analysts
 — +19.5% ·
LFCR
Lifecore Biomedical
 May 06, 2026 BUY Strong Buy
+98.4% avg upside
10 analysts
 — +1.0% ·
IQV
IQVIA Holdings
 May 05, 2026 BUY Strong Buy
+1.4% avg upside
39 analysts
 — +36.9% ·
CAH
Cardinal Health
 Apr 28, 2026 BUY Strong Buy
-13.5% avg upside
29 analysts
 — +12.9% ·
MEDP
Medpace Holdings
 Apr 23, 2026 HOLD Buy
-19.0% avg upside
17 analysts
$393.00
34.55% Downside
 +47.9% ·
FTRE
Fortrea Holdings Inc.
 Feb 26, 2026 HOLD Buy
+14.5% avg upside
12 analysts
 — +34.5% ·
🔒 8 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Max Smock — Frequently Asked Questions
How accurate are Max Smock's stock ratings?
Based on the calls 13Foresight could measure, about 95% of Max's ratings were profitable over a one-year hold, with an average return of +18.8% per rating, or +14.1% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Max ranked on 13Foresight?
Max Smock is currently ranked #17 with a 5-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Max cover?
Max most recently has ratings on CERT, SHC, CH:SFZN, SLP, CRL, ICLR, COR, MCK, LFCR, IQV, CAH, MEDP and 1 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.